Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that eligible women take up breast cancer screening in Sutton Coldfield constituency.
Through our National Health Service screening programmes, we can reduce mortality and morbidity from cancer in the population who appear healthy and have no symptoms, by detecting conditions at an earlier, more treatable stage. Each year, over 15 million people are invited for screening, with over 10 million taking up the invitation.
In Birmingham and Solihull, between 2022/23 and 2023/24 there has been an improvement of 4.93% in breast cancer screening uptake in 53 to 70 year old people.
In Sutton Coldfield, the breast screening is offered to all eligible cohorts in line with service specifications of the NHS Breast Screening Programme. In this constituency, uptake and coverage are stable and constituents can access screening at both static and mobile facilities. There is a dedicated focus on reducing health inequalities, supporting access, and informing eligible patients to actively take up their screening appointment and offer.
The breast screening service in Sutton Coldfield is currently undertaking a targeted text messaging initiative targeting eligible patients that have not attended their screening invitation. This includes the offer to rebook their screening appointment and a link to bilingual breast screening videos to support education and awareness. A follow-up text message survey is also being used to explore barriers to attendance and motivating factors, with insights informing ongoing service development.
Other initiatives to increase uptake in the area include:
a dedicated general practice toolkit to support and inform health promotion messaging;
a breast screening resource pack for care homes to support staff in promoting screening awareness and facilitating uptake amongst eligible residents; and
a cancer bus initiative promoting a range of services including breast cancer screening.